120 related articles for article (PubMed ID: 10365571)
1. Serum soluble L-selectin in childhood acute lymphoblastic leukemia.
Olejnik I
Pediatr Int; 1999 Jun; 41(3):246-8. PubMed ID: 10365571
[TBL] [Abstract][Full Text] [Related]
2. [Clinical significance of the detection of the sL-selectin level in patients with acute leukemia].
Chang JH; Qi ZH; Xu M
Hunan Yi Ke Da Xue Xue Bao; 2002 Apr; 27(2):151-3. PubMed ID: 12575346
[TBL] [Abstract][Full Text] [Related]
3. [Plasma concentration of the shed form of L-selectin (sL-selectin) in patients with acute myeloblastic leukemia (AML) and acute lymphoblastic leukemia (ALL) and its relation to the clinical course].
Kapelko-Slowik K; Jaźwiec B; Mirosław S; Wołowiec D; Urbaniak-Kujda D; Tomaszewska-Toporska B; Potoczek S; Ciszak L; Kuliczkowski K
Pol Arch Med Wewn; 2004 Nov; 112(5):1283-8. PubMed ID: 15773509
[TBL] [Abstract][Full Text] [Related]
4. High levels of the shed form of L-selectin are present in patients with acute leukemia and inhibit blast cell adhesion to activated endothelium.
Spertini O; Callegari P; Cordey AS; Hauert J; Joggi J; von Fliedner V; Schapira M
Blood; 1994 Aug; 84(4):1249-56. PubMed ID: 7519478
[TBL] [Abstract][Full Text] [Related]
5. [Study on expression of cell surface L-selectin and soluble L-selectin in patients with acute leukemia].
Chang JH; Qi ZH; Chen FP; Xie QZ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2003 Jun; 11(3):251-5. PubMed ID: 12844406
[TBL] [Abstract][Full Text] [Related]
6. Soluble L-selectin increases in the cerebrospinal fluid prior to meningeal involvement in children with acute lymphoblastic leukemia.
Dagdemir A; Ertem U; Duru F; Kirazli S
Leuk Lymphoma; 1998 Jan; 28(3-4):391-8. PubMed ID: 9517511
[TBL] [Abstract][Full Text] [Related]
7. Soluble l-selectin (sCD62L) in relapsed childhood acute lymphoblastic leukaemia.
Herold R; Stibenz D; Hartmann R; Henze G; Bührer C
Br J Haematol; 2002 Dec; 119(3):677-84. PubMed ID: 12437644
[TBL] [Abstract][Full Text] [Related]
8. L and E selectins in acute myeloid leukemia: expression, clinical relevance and relation to patient outcome.
Aref S; Salama O; Al-Tonbary Y; Fouda M; Menessy A; El-Sherbiny M
Hematology; 2002 Apr; 7(2):83-7. PubMed ID: 12186696
[TBL] [Abstract][Full Text] [Related]
9. Serum soluble CD44 in pediatric patients with acute leukemia.
Takeuchi M; Tanizawa A; Fukumoto Y; Kikawa Y; Mayumi M
J Pediatr Hematol Oncol; 1999; 21(5):384-8. PubMed ID: 10524451
[TBL] [Abstract][Full Text] [Related]
10. CD54 and CD62L expression by lymphoid cells in acute lymphoblastic leukaemia in children.
Hafez FM; Hassab H; Morad Z; Farag EA
Br J Biomed Sci; 2003; 60(3):149-54. PubMed ID: 14560791
[TBL] [Abstract][Full Text] [Related]
11. Circulating soluble adhesion molecule levels in children with acute lymphoblastic leukaemia.
Hatzistilianou M; Athanassiadou F; Agguridaki C; Catriu D
Eur J Pediatr; 1997 Jul; 156(7):537-40. PubMed ID: 9243236
[TBL] [Abstract][Full Text] [Related]
12. Antibodies against 9-O-acetylated sialoglycans: a potent marker to monitor clinical status in childhood acute lymphoblastic leukemia.
Pal S; Bandyopadhyay S; Chatterjee M; Bhattacharya DK; Minto L; Hall AG; Mandal C
Clin Biochem; 2004 May; 37(5):395-403. PubMed ID: 15087256
[TBL] [Abstract][Full Text] [Related]
13. Soluble L-selectin levels in type I diabetes mellitus: a surrogate marker for disease activity?
Kretowski A; Gillespie KM; Bingley PJ; Kinalska I
Immunology; 2000 Feb; 99(2):320-5. PubMed ID: 10692053
[TBL] [Abstract][Full Text] [Related]
14. A fluorometric assay for L-asparaginase activity and monitoring of L-asparaginase therapy.
Ylikangas P; Mononen I
Anal Biochem; 2000 Apr; 280(1):42-5. PubMed ID: 10805519
[TBL] [Abstract][Full Text] [Related]
15. Plasma soluble L-selectin following cardiopulmonary bypass (CPB) in children: is it a marker of the postoperative course?
Dagan O; Prince T; Ben-Abraham R; Vidne B; Mishaly D; Katz Y; Keller N; Barzilay Z; Paret G
Med Sci Monit; 2002 Jul; 8(7):CR467-72. PubMed ID: 12118192
[TBL] [Abstract][Full Text] [Related]
16. Anti-asparaginase antibodies following E. coli asparaginase therapy in pediatric acute lymphoblastic leukemia.
Woo MH; Hak LJ; Storm MC; Evans WE; Sandlund JT; Rivera GK; Wang B; Pui CH; Relling MV
Leukemia; 1998 Oct; 12(10):1527-33. PubMed ID: 9766495
[TBL] [Abstract][Full Text] [Related]
17. Correlation between serum level of soluble L-selectin and leukocyte count in chronic myeloid and lymphocytic leukemia and during bone marrow transplantation.
Zetterberg E; Richter J
Eur J Haematol; 1993 Aug; 51(2):113-9. PubMed ID: 7690331
[TBL] [Abstract][Full Text] [Related]
18. Soluble adhesion molecules in children and young adults with chronic renal failure treated conservatively.
Musiał K; Zwolińska D; Berny U; Polak-Jonkisz D; Szprynger K; Szczepańska M
Rocz Akad Med Bialymst; 2004; 49():209-12. PubMed ID: 15631345
[TBL] [Abstract][Full Text] [Related]
19. Development of anti-asparaginase antibodies in childhood acute lymphoblastic leukemia.
Zalewska-Szewczyk B; Andrzejewski W; Bodalski J
Pediatr Blood Cancer; 2004 Oct; 43(5):600-2. PubMed ID: 15382279
[TBL] [Abstract][Full Text] [Related]
20. Are elevated serum levels of IGFBP-2 after intensive chemotherapy of childhood acute lymphoblastic leukemia a risk factor of relapse?
Kitszel A; Krawczuk-Rybak M
Adv Med Sci; 2007; 52():147-53. PubMed ID: 18217408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
